This is a rare but serious reaction that can happen after a blood transfusion. It causes fluid to build up in the lungs, making it hard to breathe. It's different from simply getting too much fluid too quickly.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Transfusion-related acute lung injury (TRALI) is a rare but serious reaction to a blood transfusion in which the tiny blood vessels in the lungs become inflamed and leaky. Fluid seeps into the air sacs, so oxygen has a harder time reaching the blood. It begins during a transfusion or within 6 hours afterward, and it usually comes on quickly. The main sign is sudden shortness of breath with a falling oxygen level. People may also have a fever, a cough, a fast heartbeat, a drop in blood pressure that causes dizziness or fainting, or a bluish tinge to the lips or nails. TRALI is one of the leading causes of serious harm and death linked to transfusion, which is why hospital teams watch for it closely. It can follow any type of blood product, including red cells, platelets and plasma, the liquid part of blood.
TRALI is generally explained as a two-step process. The first step is the recipient's own condition. Serious illness such as sepsis (a body-wide reaction to infection), major trauma, recent major surgery, a blood cancer, advanced liver disease or being on a breathing machine puts the lungs in an inflamed, primed state. The second step is something in the transfused blood that sets off that primed system. Often this is a donor antibody that reacts with the recipient's white blood cells; in other cases it is inflammatory substances that build up in blood products during storage. This explains why TRALI tends to occur in people who are already very ill, although it can also happen in someone who was otherwise well. Products that contain a lot of plasma, such as fresh frozen plasma and some platelet units, have carried the highest risk. Pregnancy can lead a woman to form antibodies against other people's white blood cells, so plasma from donors with past pregnancies is more likely to cause TRALI. Blood suppliers in the United States and other countries now collect plasma mainly from male donors or test some female donors for these antibodies, and this has substantially reduced TRALI. Receiving many units of blood in a short time also raises the risk. None of these factors means a reaction was predictable in an individual case, and TRALI cannot be completely prevented.
TRALI is diagnosed by a care team at the bedside rather than by a single test. Clinicians look for breathing difficulty and low oxygen that begin during or within 6 hours of a transfusion, together with a chest X-ray or other scan showing new fluid in both lungs. Oxygen is tracked with a fingertip pulse oximeter and sometimes an arterial blood gas, a blood sample that measures oxygen directly. The most important distinction is from transfusion-associated circulatory overload (TACO), where the lungs fill with fluid because more volume was given than the heart and circulation could handle. The two can look alike, but they are treated differently: TACO usually improves with diuretics (water pills), while in TRALI the vessels are leaking rather than overfilled, and diuretics can worsen low blood pressure. To tell them apart, clinicians consider fluid balance and blood pressure and may use an echocardiogram (an ultrasound of the heart) or a blood test for B-type natriuretic peptide (BNP), a hormone that tends to be higher when the heart is under strain. They also consider other causes, such as a severe allergic reaction, infection or lung injury from an existing illness. The blood bank may test the donors for white-cell antibodies. Those results can take weeks and help prevent future cases, but they are not needed to make the diagnosis.
When TRALI is suspected, the transfusion is stopped immediately. There is no medicine that reverses the lung injury itself, so treatment supports breathing and circulation while the lungs heal. Milder cases may need only extra oxygen through nasal tubes or a mask, or high-flow oxygen or a pressurized mask. Many people with TRALI, often most in reported case series, need a breathing tube and ventilator in intensive care for a few days. If blood pressure falls too low, fluids or medicines that raise blood pressure may be given. The team manages fluids carefully, since giving too much can add to the lung fluid. Steroids are not routinely recommended, because studies have not shown that they improve recovery from TRALI, although they may be considered when another inflammatory illness is also present. Taking antihistamines or steroids before a transfusion does not prevent TRALI. The hospital reports the reaction to the blood bank, which traces the donors involved. A donor found to carry the responsible antibodies can be stopped from giving plasma or platelets in the future, which protects other patients.
TRALI is usually short-lived. Oxygen levels often begin to improve within a day or two, and most people recover within about 2 to 4 days. People who need a ventilator may stay longer in intensive care, and the overall hospital stay often depends as much on the illness that required the transfusion as on TRALI itself. TRALI can be fatal, and the risk is highest in people who were already critically ill. For those who recover, the lungs generally heal fully: in the limited studies available, long-term lung function in survivors appears similar to that of people who never had TRALI. Because the reaction usually comes from a particular donor product rather than from the recipient's own body, the investigation focuses on the donors. Before any future transfusion, it is worth making sure the episode is recorded in your medical record and discussing it with the team.
TRALI starts during or within 6 hours of a transfusion, so it usually happens while someone is still being monitored. If you are receiving blood and suddenly feel short of breath, start coughing, or feel feverish, dizzy or faint, tell the nurse right away so the transfusion can be stopped and you can be checked. If you go home after an outpatient transfusion and develop new shortness of breath, bluish lips or nails, or lightheadedness or fainting in the hours afterward, call 911 or go to the emergency department, and tell the staff you recently had a transfusion.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Transfusion-Related Acute Lung Injury is like, what's helped you, or ask the community a question.